Akito Tanoue Selected Research

Vasopressin Receptors (Arginine Vasopressin Receptor)

4/2013	Decreased expression of aquaporin 2 in the collecting duct of mice lacking the vasopressin V1a receptor.
10/2012	Vasopressin V1a receptor is required for nucleocytoplasmic transport of mineralocorticoid receptor.
4/2011	Aldosterone requires vasopressin V1a receptors on intercalated cells to mediate acid-base homeostasis.
7/2010	Decreased susceptibility to salt-induced hypertension in subtotally nephrectomized mice lacking the vasopressin V1a receptor.
11/2009	Enhanced effect of neuropeptide Y on food intake caused by blockade of the V(1A) vasopressin receptor.
6/2009	Both V(1A) and V(1B) vasopressin receptors deficiency result in impaired glucose tolerance.
10/2007	Insulin hypersensitivity in mice lacking the V1b vasopressin receptor.
3/2007	Vasopressin promotes cardiomyocyte hypertrophy via the vasopressin V1A receptor in neonatal mice.
3/2007	Vasopressin V1A receptor enhances baroreflex via the central component of the reflex arc.
4/2006	[Vasopressin receptor knockout mice as an animal model of psychiatric disorders].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Akito Tanoue Research Topics

Disease

7	Neuroblastoma 01/2011 - 09/2006
5	Insulin Resistance 02/2011 - 06/2007
4	Cardiomyopathies (Cardiomyopathy) 03/2013 - 01/2007
4	Hypertension (High Blood Pressure) 07/2010 - 07/2002
3	Hyperglycemia 02/2011 - 06/2009
3	Hypertrophy 03/2007 - 11/2004
3	Inborn Genetic Diseases (Disease, Hereditary) 11/2006 - 09/2002
2	Hemolysis 01/2018 - 05/2014
2	Drug-Related Side Effects and Adverse Reactions 01/2017 - 01/2011
2	Neoplasms (Cancer) 01/2015 - 07/2008
2	Hepatocellular Carcinoma (Hepatoma) 01/2015 - 01/2013
2	Pelizaeus-Merzbacher Disease 10/2014 - 07/2012
2	Acidosis 12/2013 - 04/2011
2	Renal Tubular Acidosis (Distal Renal Tubular Acidosis) 10/2012 - 04/2011
2	Glucose Intolerance 02/2011 - 06/2009
2	Hypoglycemia (Reactive Hypoglycemia) 02/2011 - 06/2009
2	Mood Disorders (Mood Disorder) 12/2010 - 12/2008
2	Bipolar Disorder (Manic Depressive Psychosis) 11/2009 - 07/2008
2	Cardiomegaly (Heart Hypertrophy) 05/2007 - 03/2007
2	Vascular Remodeling 05/2007 - 11/2004
2	Hypotension (Low Blood Pressure) 03/2007 - 03/2002
2	Tyrosinemias (Tyrosinemia) 11/2006 - 01/2003
2	Lymphoma (Lymphomas) 07/2006 - 10/2005
2	Neoplasm Metastasis (Metastasis) 07/2006 - 10/2005
1	Catalepsy 12/2017
1	Paraplegia (Spastic Paraplegia) 03/2016
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2015
1	Cholangiocarcinoma 01/2015
1	Biliary Atresia 09/2014
1	Hypoxia (Hypoxemia) 06/2014
1	Protein Deficiency 06/2014
1	Ornithine Carbamoyltransferase Deficiency Disease 03/2014
1	Peripheral Nervous System Diseases (PNS Diseases) 10/2013
1	Dehydration (Water Stress) 04/2013
1	Carcinoma (Carcinomatosis) 01/2013
1	Microphthalmos 01/2011
1	Intellectual Disability (Idiocy) 01/2011
1	Ectrodactyly 01/2011

Drug/Important Bio-Agent (IBA)

10	Vasopressin Receptors (Arginine Vasopressin Receptor)IBA 04/2013 - 04/2006
7	Proteins (Proteins, Gene)FDA Link 06/2014 - 06/2007
7	Vasopressins (Vasopressin)IBA 12/2013 - 05/2006
5	CatecholaminesIBA 05/2007 - 07/2002
4	Pharmaceutical PreparationsIBA 01/2011 - 07/2008
4	Valproic Acid (Depakote)FDA LinkGeneric 11/2010 - 01/2007
4	SaltsIBA 07/2010 - 07/2002
4	Norepinephrine (Noradrenaline)FDA LinkGeneric 05/2007 - 03/2002
3	pyrimidin-2-one beta-ribofuranosideIBA 01/2017 - 01/2013
3	DesminIBA 04/2011 - 01/2007
3	Glucose (Dextrose)FDA LinkGeneric 06/2009 - 05/2007
3	Epinephrine (Adrenaline)FDA LinkGeneric 05/2007 - 07/2002
2	Polyvinyl Chloride (PVC)IBA 01/2018 - 05/2014
2	PlasticizersIBA 01/2018 - 05/2014
2	phthalic acid (phthalate)IBA 01/2018 - 05/2014
2	Diethylhexyl Phthalate (DEHP)IBA 01/2018 - 05/2014
2	Amino Acids FDA Link 03/2016 - 11/2006
2	A-Form DNA (A-DNA)IBA 01/2015 - 01/2013
2	DNA (Deoxyribonucleic Acid)IBA 01/2015 - 01/2013
2	MethyltransferasesIBA 01/2015 - 01/2013
2	Messenger RNA (mRNA)IBA 06/2014 - 12/2013
2	AldosteroneIBA 10/2012 - 04/2011
2	Sorting NexinsIBA 01/2011 - 11/2009
2	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 12/2010 - 12/2008
2	Insulin (Novolin)FDA Link 06/2009 - 10/2007
2	Small Heat-Shock ProteinsIBA 01/2009 - 01/2007
2	PaxillinIBA 07/2008 - 05/2007
2	JNK Mitogen-Activated Protein KinasesIBA 07/2008 - 09/2006
2	Dopamine beta-HydroxylaseIBA 05/2007 - 11/2004
2	Phenylephrine (Neo-Synephrine)FDA LinkGeneric 03/2007 - 03/2002
2	fumarylacetoacetase (fumarylacetoacetate hydrolase)IBA 11/2006 - 01/2003
2	Guanine Nucleotide Exchange Factors (Guanine Nucleotide Exchange Factor)IBA 07/2006 - 10/2005
1	Dronabinol (THC)FDA LinkGeneric 12/2017
1	Haloperidol (Haldol)FDA LinkGeneric 12/2017
1	ArsenicIBA 01/2015
1	Indicators and Reagents (Reagents)IBA 01/2015
1	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 09/2014
1	Erythropoietin FDA Link 06/2014
1	adipic acid (adipate)IBA 05/2014
1	Citric Acid (Citrate)FDA LinkGeneric 05/2014
1	diisodecyl phthalateIBA 05/2014
1	2,3- dihydro- 5H- oxazolo(3,2- a)thieno(3,2- d)pyrimidin- 5- oneIBA 05/2014
1	Adenine FDA LinkGeneric 05/2014
1	Phosphates (Orthophosphate)IBA 05/2014
1	Mannitol (Osmitrol)FDA LinkGeneric 05/2014
1	diisononyl 1,2-cyclohexanedicarboxylic acidIBA 05/2014
1	cytohesin-1IBA 10/2013
1	Aquaporin 2IBA 04/2013
1	Phenobarbital (Luminal)FDA Link 04/2013
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 03/2013
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 07/2012
1	Membrane Proteins (Integral Membrane Proteins)IBA 07/2012
1	Proton-Translocating ATPases (ATPase, H+)IBA 04/2011
1	Ammonium CompoundsIBA 04/2011
1	MineralocorticoidsIBA 04/2011
1	Adenosine Triphosphatases (ATPase)IBA 04/2011
1	FludrocortisoneIBA 04/2011
1	mono(2-methacryloyloxy)ethyl phthalate (MMEP)IBA 01/2011
1	EnzymesIBA 01/2011

Therapy/Procedure

2	Therapeutics 10/2014 - 10/2013
1	Drug Therapy (Chemotherapy) 01/2015
1	Transplantation 03/2014